Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMBALAL SARABHAI Gains 6%; BSE HEALTHCARE Index Up 0.6%
Wed, 3 Jul 11:38

AMBALAL SARABHAI Gains 6%; BSE HEALTHCARE Index Up 0.6%Image source: Kameleon007 /www.istockphoto.com

AMBALAL SARABHAI share price has zoomed 6% and is presently trading at Rs 49.0.

Meanwhile, the BSE HEALTHCARE index is at 37,395.2 (up 0.6%).

Among the top gainers in the BSE HEALTHCARE index today are SUN PHARMA ADV. RES. (up 2.8%) and FORTIS HEALTHCARE (up 2.6%).

ALEMBIC PHARMA (down 2.0%) and AARTI DRUGS (down 1.7%) are among the top losers today.

Over the last one year, AMBALAL SARABHAI has moved up from Rs 28.5 to Rs 49.0, registering a gain of Rs 20.5 (up 72.2%).

On the other hand, the BSE HEALTHCARE index has moved up from 25,627.6 to 37,395.2, registering a gain of 45.9% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Glenmark Pharma (up 90.4%), Cadila Healthcare (up 90.2%) and GSK Pharma (up 87.5%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 79,882.2 (up 0.6%).

The top gainers among the BSE Sensex today are HDFC Bank (up 3.1%) and Axis Bank (up 1.9%). The most traded stocks in the BSE Sensex are Tata Steel and HDFC Bank.

In the meantime, NSE Nifty is at 24,265.5 (up 0.6%). HDFC Bank and Tata Consumer Products are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,205.1 to 79,882.2, registering a gain of 14,677.2 points (up 22.5%).

AMBALAL SARABHAI Financial Update...

AMBALAL SARABHAI net profit grew 131.5% YoY to Rs 101 million for the quarter ended March 2024, compared to a profit of Rs 44 million a year ago. Net sales rose 22.3% to Rs 543 million during the period as against Rs 444 million in January-March 2023.

For the year ended March 2024, AMBALAL SARABHAI reported 50.4% decrease in net profit to Rs 57 million compared to net profit of Rs 114 million during FY23. Revenue of the company grew 1.9% to Rs 1,736 million during FY24.

The current Price to earnings ratio of AMBALAL SARABHAI, based on rolling 12 month earnings, stands at 44.7.


Equitymaster requests your view! Post a comment on "AMBALAL SARABHAI Gains 6%; BSE HEALTHCARE Index Up 0.6%". Click here!